SMETS PHARMA
ActiveSummary
SMETS PHARMA has been active since 1968 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €241,620 and a net result of €40,740. Equity remains stable across the filed fiscal years (±0.1% per year). Its solvency ranks better than 66% of 10485 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability54▲+3
Solvency78▲+5
Growth78▲+20
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €16,000 at 30 days acceptable
Liquidity ample (current ratio 1.94 against 1.83 in 2024; short-term debt: 45.3% and cash: 11.9% of total assets), and 46.6% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
53.4%
Return on assets
9%
Age of the figures
9 mo
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €241,620
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
24 d early
2024
34 d early
2023
103 d early
2022
98 d early
2021
72 d early
2020
5 d late
2019
78 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 58 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Source amounts without an identifiable currency are assumed to be EUR.
Equity
€241,620▲ 19.8%
2024 · €201,739
Total assets
€452,862▲ 6.8%
2024 · €424,162
Net result
€40,740▲ 8.8%
2024 · €37,430
Working capital
€193,159▲ 8.2%
2024 · €178,455
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€13,625▼ 60.4%€27,268▲ 100%€69,973▲ 157%€84,705▲ 21.1%€83,769▼ 1.1%
Net result-€4,030below the sector's middle half€5,426within the sector's middle half€27,607within the sector's middle half▲ 409%€37,430within the sector's middle half▲ 35.6%€40,740within the sector's middle half▲ 8.8%
Equity€245,524within the sector's middle half▼ 1.6%€250,950within the sector's middle half▲ 2.2%€165,169within the sector's middle half▼ 34.2%€201,739within the sector's middle half▲ 22.1%€241,620within the sector's middle half▲ 19.8%
Total assets€344,730below the sector's middle half▲ 5.0%€347,942below the sector's middle half▲ 0.9%€396,501below the sector's middle half▲ 14.0%€424,162below the sector's middle half▲ 7.0%€452,862within the sector's middle half▲ 6.8%
Debt€99,206▲ 8.5%€96,992▼ 2.2%€231,333▲ 139%€222,423▼ 3.9%€211,242▼ 5.0%
Working capital€195,513▼ 7.4%€209,639▲ 7.2%€143,483▼ 31.6%€178,455▲ 24.4%€193,159▲ 8.2%
Solvency71.2%above the sector's middle half▼ 4.8pp72.1%above the sector's middle half▲ 0.9pp41.7%within the sector's middle half▼ 30.5pp47.6%within the sector's middle half▲ 5.9pp53.4%within the sector's middle half▲ 5.8pp
Staff (FTE)2.3within the sector's middle half▲ 4.5%2.3within the sector's middle half=2.3within the sector's middle half=2.3within the sector's middle half=2.2within the sector's middle half▼ 4.3%
above
within
below
the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 1% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €452,862
Fixed assets
€54,624 ▲ 77.7%
Current assets
€398,238 ▲ 1.2%
Equity and liabilities €452,862
Equity
€241,620 ▲ 19.8%
Debt
€211,242 ▼ 5.0%
Debt's share of the balance-sheet total falls from 52.4% to 46.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€92,441▼
2024 · €93,823
Cash flow
€49,412▲
2024 · €46,548
Current ratio
1.94▲
2024 · 1.83
Quick ratio
1.01▼
2024 · 1.06
Debt to equity
0.87▼
2024 · 1.10
ROE
16.9%▼
2024 · 18.6%
ROA
9.0%▲
2024 · 8.8%
Interest coverage
2.82▲
2024 · 2.54
Debt ≤ 1 year
€205,080▼
2024 · €214,965
Income taxes
€16,429▲
2024 · €12,834
Staff costs
€179,052▼
2024 · €181,544
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 31,324 companies that looked in July 2024 the way this one looks now, 0.4% went bankrupt within 24 months and 93% are still going.
- Micro
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.4%
went bankrupt
5.9%
stopped otherwise
93%
still going
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.4% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.6% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 31,324 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €131,890 | €162,244 | €179,875 | €181,544 | €179,052 | ▼ 1.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €8,721 | €10,754 | €9,581 | €9,118 | €8,672 | ▼ 4.9% |
| Other operating charges640/8 | €2,141 | €2,491 | €3,045 | €2,404 | €2,397 | ▼ 0.3% |
| Gross operating margin9900 | €156,377 | €202,756 | €262,474 | €277,771 | €273,890 | ▼ 1.4% |
| Operating profit (loss)9901 | €13,625 | €27,268 | €69,973 | €84,705 | €83,769 | ▼ 1.1% |
| Financial income75/76B | €1,888 | €2,155 | €3,220 | €2,539 | €6,126 | ▲ 141% |
| Recurring financial income75 | €1,888 | €2,155 | €3,220 | €2,539 | €6,126 | ▲ 141% |
| Financial charges65/66B | €19,543 | €23,520 | €34,832 | €36,980 | €32,726 | ▼ 11.5% |
| Recurring financial charges65 | €19,543 | €23,520 | €34,832 | €36,980 | €32,726 | ▼ 11.5% |
| Profit (loss) for the period before taxes9903 | -€4,030 | €5,903 | €38,361 | €50,264 | €57,169 | ▲ 13.7% |
| Income taxes67/77 | - | €477 | €10,754 | €12,834 | €16,429 | ▲ 28.0% |
| Profit (loss) for the period9904 | -€4,030 | €5,426 | €27,607 | €37,430 | €40,740 | ▲ 8.8% |
| Profit (loss) for the period to be appropriated9905 | -€4,030 | €5,426 | €27,607 | €37,430 | €40,740 | ▲ 8.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €344,730 | €347,942 | €396,501 | €424,162 | €452,862 | ▲ 6.8% |
| Fixed assets21/28 | €50,887 | €42,325 | €32,744 | €30,743 | €54,624 | ▲ 77.7% |
| Tangible fixed assets22/27 | €45,887 | €37,325 | €27,744 | €25,743 | €49,624 | ▲ 92.8% |
| Land and buildings22 | €8,676 | €8,676 | €8,676 | €10,367 | €41,075 | ▲ 296% |
| Plant, machinery and equipment23 | €33,994 | €25,273 | €17,343 | €10,893 | €5,934 | ▼ 45.5% |
| Furniture and vehicles24 | €3,217 | €3,376 | €1,725 | €4,482 | €2,615 | ▼ 41.7% |
| Financial fixed assets28 | €5,000 | €5,000 | €5,000 | €5,000 | €5,000 | = |
| Current assets29/58 | €293,843 | €305,617 | €363,758 | €393,419 | €398,238 | ▲ 1.2% |
| Stocks and contracts in progress3 | €135,718 | €132,086 | €153,969 | €164,984 | €190,481 | ▲ 15.5% |
| Stocks30/36 | €135,718 | €132,086 | €153,969 | €164,984 | €190,481 | ▲ 15.5% |
| Amounts receivable within one year40/41 | €67,516 | €65,758 | €74,635 | €72,784 | €77,695 | ▲ 6.7% |
| Trade receivables40 | €57,619 | €61,015 | €71,101 | €71,160 | €77,278 | ▲ 8.6% |
| Other amounts receivable41 | €9,897 | €4,742 | €3,534 | €1,624 | €418 | ▼ 74.3% |
| Current investments50/53 | €1,299 | €32,299 | €43,133 | €64,432 | €61,059 | ▼ 5.2% |
| Cash at bank and in hand54/58 | €75,147 | €62,133 | €71,722 | €74,590 | €53,935 | ▼ 27.7% |
| Deferred charges and accrued income490/1 | €14,163 | €13,341 | €20,300 | €16,628 | €15,068 | ▼ 9.4% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €344,730 | €347,942 | €396,501 | €424,162 | €452,862 | ▲ 6.8% |
| Equity10/15 | €245,524 | €250,950 | €165,169 | €201,739 | €241,620 | ▲ 19.8% |
| Contributions10/11 | €79,468 | €79,468 | €104,468 | €104,468 | €104,468 | = |
| Reserves13 | €170,086 | €171,482 | €60,701 | €97,271 | €137,152 | ▲ 41.0% |
| Tax-exempt reserves132 | €89 | €89 | €89 | €89 | €89 | = |
| Distributable reserves133 | €169,997 | €171,393 | €60,612 | €97,183 | €137,064 | ▲ 41.0% |
| Profit (loss) carried forward14 | -€4,030 | - | - | - | - | - |
| Amounts payable17/49 | €99,206 | €96,992 | €231,333 | €222,423 | €211,242 | ▼ 5.0% |
| Amounts payable within one year42/48 | €98,330 | €95,978 | €220,275 | €214,965 | €205,080 | ▼ 4.6% |
| Trade debts44 | €45,919 | €44,473 | €55,216 | €53,787 | €57,225 | ▲ 6.4% |
| Suppliers440/4 | €45,919 | €44,473 | €55,216 | €53,787 | €57,225 | ▲ 6.4% |
| Taxes, remuneration and social security45 | €22,658 | €19,208 | €26,996 | €28,594 | €26,754 | ▼ 6.4% |
| Taxes450/3 | €5 | - | €4,991 | €6,285 | €4,717 | ▼ 24.9% |
| Remuneration and social security454/9 | €22,653 | €19,208 | €22,005 | €22,309 | €22,037 | ▼ 1.2% |
| Other amounts payable47/48 | €29,754 | €32,296 | €138,062 | €132,583 | €121,101 | ▼ 8.7% |
| Accrued charges and deferred income492/3 | €876 | €1,015 | €11,058 | €7,458 | €6,162 | ▼ 17.4% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€4,030 | €5,426 | €27,607 | €37,430 | €40,740 | ▲ 8.8% |
| + Depreciation and write-downs630 | €8,721 | €10,754 | €9,581 | €9,118 | €8,672 | ▼ 4.9% |
| Operating cash flow (approximation) | €4,691 | €16,180 | €37,188 | €46,548 | €49,412 | ▲ 6.2% |
| Investment in fixed assets (approximation) | - | -€2,192 | €0 | -€7,117 | -€32,553 | ▼ 357% |
| Change in cash | - | -€13,014 | €9,589 | €2,869 | -€20,656 | ▼ 820% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
07-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Highest result since 2018net €40,740 ▲8.8%
Net result €40,740, the highest in the series.
27-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Equity above €200,000Eq €201,739 ▲22.1%
3 profitable years in a row build equity to €201,739.
19-04
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
24-04
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Back to profitnet €5,426
Net result €5,426 after one loss-making year.
20-05
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
31-12
Financial
Weakest financial yearnet -€4,030
Net result drops to -€4,030, the lowest in the series; recovery starts the following year.
05-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 5 days late
2020
14-05
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
27-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
05-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
29-08
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 29 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 7 acts read
About the unread acts
We know of 7 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
7 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Lier · 1 establishment unit since 1960
Ground area
363 m²
Building footprint
195 m²
Volume, LiDAR
1,471 m³
Parcel 12392A0557/00Y007, Flanders · tallest building 11.9 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Antwerpsesteenweg 36 3, 2500 Lier
since 19602.005.811.728
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12392A0557/00Y007 | Flanders | 363 m² | 1 · 195 m² | 11.8 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 · 1 entry · 75 EUR awarded| Year | Entries | awarded | paid |
|---|---|---|---|
| 2022 | 1 | 75 EUR | 0 EUR |
Similar companies · same sector, comparable size
WIJMENPUT
BE 0666.915.283
Aalst · Eq €241,729
APOTHEEK DESCHILDER
BE 0889.943.029
Brugge · Eq €241,899
PharmaSil
BE 1007.715.677
Antwerpen · Eq €241,248
DIEPENBEEK MARKT FARMA
BE 0467.158.334
Diepenbeek · Eq €242,155
Apotheek Ruysschaert K.
BE 0507.732.840
Mol · Eq €242,173
Of 5,220 companies in sector 47730 we hold annual accounts for 3,860. 3,539 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded01-01-1968
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
47750Retail sale of cosmetics and toilet articles
E-invoicing
Reachable via Peppol
Peppol ID
0208:0404059834
Also
9925:BE0404059834
Registered
24-11-2023
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
General meetings
1 convocationGeneral meeting
Jaarverslag. Goedkeuring jaarrekening. Bestemming resultaat. Kwijting bestuurders. (Her)Benoemingen. Divers. (AOPC-1-9-01867/16.04)